GILD | Gilead Sciences Inc | $207.7b | $168.97 | +1.1% | 1.9M |
ACLX | Arcellx, Inc. Common Stock | $6.7b | $115.06 | -0.0% | 16.1M |
IOVA | Iovance Biotherapeutics, Inc. Common Stock | $4.0b | $7.32 | -2.3% | 4.4M |
NTLA | Intellia Therapeutics, Inc | $1.7b | $9.75 | -0.9% | 2.2M |
VOR | Vor Biopharma Inc. Common Stock | $1.2b | $18.06 | -3.9% | 303.5K |
IMTX | Immatics N.V. Ordinary Shares | $1.1b | $6.14 | -0.2% | 335.9K |
SANA | Sana Biotechnology, Inc. Common Stock | $0.7b | $1.86 | -0.3% | 883.7K |
IMMX | Immix Biopharma, Inc. Common Stock | $0.6b | $7.21 | -2.9% | 289.9K |
YDES | YD Bio Limited Ordinary Shares | $453.0m | $4.74 | -3.0% | 21.5K |
ALLO | Allogene Therapeutics, Inc. Common Stock | $386.9m | $0.76 | -6.1% | 2.5M |
IPSC | Century Therapeutics, Inc. Common Stock | $275.2m | $1.49 | -8.5% | 174.4K |
LYEL | Lyell Immunopharma, Inc. Common Stock | $263.9m | $13.50 | -7.6% | 62.4K |
FATE | Fate Therapeutics, Inc. | $244.4m | $1.03 | -8.8% | 1.2M |
ARTV | Artiva Biotherapeutics, Inc. Common Stock | $205.3m | $3.85 | -2.5% | 614.5K |
TARA | Protara Therapeutics, Inc. Common Stock | $146.6m | $2.29 | -3.4% | 197.1K |
NKTX | Nkarta, Inc. Common Stock | $109.6m | $1.21 | 0.0% | 450.7K |
ENGN | enGene Therapeutics Inc. Common Stock | $108.6m | $1.80 | -4.8% | 664.6K |
ANIX | Anixa Biosciences, Inc. | $106.2m | $2.65 | +4.3% | 71.5K |
TVGN | Tevogen Inc. Common Stock | $93.2m | $5.82 | -7.3% | 454 |
ATRA | Atara Biotherapeutics, Inc | $82.3m | $6.11 | 0.0% | 19.8K |
COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $66.7m | $16.39 | -0.1% | 105.9K |
INKT | MiNK Therapeutics, Inc. Common Stock | $55.1m | $9.48 | 0.0% | 12.1K |
CRBU | Caribou Biosciences, Inc. Common Stock | $49.3m | $0.34 | -2.9% | 1.1M |
ACET | Adicet Bio, Inc. Common Stock | $29.7m | $2.75 | +1.5% | 98.5K |
BCTX | Briacell Therapeutics Corp. Common Shares | $26.5m | $3.43 | +8.5% | 71.1K |
CELU | Celularity Inc. Class A Common Stock | $26.5m | $0.58 | -6.5% | 114.5K |
ESLA | Estrella Immunopharma, Inc. Common Stock | $18.2m | $0.35 | -7.8% | 409.0K |
TCRX | TScan Therapeutics, Inc. Common Stock | $12.8m | $0.14 | +3.4% | 130.1K |
GDTC | CytoMed Therapeutics Limited Ordinary Shares | $10.9m | $0.78 | 0.0% | 6.5K |
INAB | IN8bio, Inc. Common Stock | $9.4m | $0.88 | +0.6% | 28.1K |
SNTI | Senti Biosciences Holdings, Inc. Common Stock | $6.8m | $0.10 | -26.0% | 427.5K |
LNAI | Lunai Bioworks Inc. Common Stock | $5.9m | $0.10 | 0.0% | N/A |
PMCB | PharmaCyte Biotech, Inc. Common Stock | $3.7m | $5.58 | -1.1% | 2.3K |
MBIO | Mustang Bio, Inc. | $3.1m | $0.40 | 0.0% | 6.0K |
ERNA | Ernexa Therapeutics Inc. Common Stock | $2.4m | $1.62 | 0.0% | 18.7K |
CLDI | Calidi Biotherapeutics, Inc. | $1.9m | $0.58 | -4.5% | 6.1K |